Anil P. Bidkar

940 total citations
31 papers, 549 citations indexed

About

Anil P. Bidkar is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Biomaterials. According to data from OpenAlex, Anil P. Bidkar has authored 31 papers receiving a total of 549 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Radiology, Nuclear Medicine and Imaging, 11 papers in Molecular Biology and 8 papers in Biomaterials. Recurrent topics in Anil P. Bidkar's work include Radiopharmaceutical Chemistry and Applications (10 papers), Medical Imaging Techniques and Applications (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Anil P. Bidkar is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (10 papers), Medical Imaging Techniques and Applications (7 papers) and Nanoparticle-Based Drug Delivery (5 papers). Anil P. Bidkar collaborates with scholars based in India, United States and United Arab Emirates. Anil P. Bidkar's co-authors include Siddhartha Sankar Ghosh, Pallab Sanpui, Sunanda Chatterjee, Robert R. Flavell, Henry F. VanBrocklin, Anirban Bhunia, Parameswar Krishnan Iyer, Siddhartha Sankar Ghosh, Debasish Barman and Pachaiyappan Rajamalli and has published in prestigious journals such as Nature Communications, Chemical Communications and Scientific Reports.

In The Last Decade

Anil P. Bidkar

29 papers receiving 541 citations

Peers

Countries citing papers authored by Anil P. Bidkar

Since Specialization

Citations

This map shows the geographic impact of Anil P. Bidkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anil P. Bidkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anil P. Bidkar more than expected).

Fields of papers citing papers by Anil P. Bidkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anil P. Bidkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anil P. Bidkar. The network helps show where Anil P. Bidkar may publish in the future.

Co-authorship network of co-authors of Anil P. Bidkar

This figure shows the co-authorship network connecting the top 25 collaborators of Anil P. Bidkar. A scholar is included among the top collaborators of Anil P. Bidkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anil P. Bidkar. Anil P. Bidkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of Donor in Purely Organic Triplet Harvesting AIE‐TADF Photosensitizer for Image‐guided Photodynamic Therapy 2025 ·Small ·Debasish Barman, Pachaiyappan Rajamalli, Anil P. Bidkar, (unknown), (unknown), Eli Zysman‐Colman, Parameswar Krishnan Iyer	8
2	Evaluation of ¹³⁴Ce/¹³⁴La-PSMA-617 for PET Imaging and Auger Electron Therapy of Prostate Cancer 2025 ·Journal of Nuclear Medicine ·Kondapa Naidu Bobba, (unknown), Anil P. Bidkar, (unknown), (unknown), Nancy Greenland, David M. Wilson, Youngho Seo, Henry F. VanBrocklin, Robert R. Flavell	0
3	A Sparse Uncollimated γ Counter Network for In Vivo Dose Reconstruction in 225Ac-Based Targeted Alpha Therapy 2024 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), Anil P. Bidkar, (unknown), Richard A. Flavell, (unknown), (unknown)	0
4	Development of CD46 targeted alpha theranostics in prostate cancer using ¹³⁴Ce/²²⁵Ac-Macropa-PEG₄-YS5 2024 ·Theranostics ·Kondapa Naidu Bobba, Anil P. Bidkar, (unknown), Niranjan Meher, (unknown), (unknown), Scott Bidlingmaier, Li Zhang, David M. Wilson, Emily Chan, Nancy Greenland, Rahul Aggarwal, Henry F. VanBrocklin, Jiang He, Jonathan Chou, Youngho Seo, Bin Liu, Robert R. Flavell	13
5	3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer 2024 ·Scientific Reports ·(unknown), Anil P. Bidkar, Kondapa Naidu Bobba, (unknown), Chandrashekhar Dasari, Niranjan Meher, (unknown), Adam Oskowitz, Bin Liu, Brian W. Miller, K. Vetter, Robert R. Flavell, Youngho Seo	6
6	Actinium-225 targeted alpha particle therapy for prostate cancer 2024 ·Theranostics ·Anil P. Bidkar, (unknown), (unknown), Henry F. VanBrocklin, Robert R. Flavell	26
7	A Technique to Quantify Very Low Activities in Regions of Interest With a Collimatorless Detector 2024 ·IEEE Transactions on Medical Imaging ·J. Caravaca, Kondapa Naidu Bobba, (unknown), (unknown), G.T. Gullberg, Anil P. Bidkar, Robert R. Flavell, Youngho Seo	1
8	Coded aperture and Compton imaging for the development of ²²⁵Ac‐based radiopharmaceuticals 2023 ·Medical Physics ·(unknown), (unknown), (unknown), Lucian Mihailescu, Anil P. Bidkar, Robert R. Flavell, K. Vetter	7
9	Evaluation of¹³⁴Ce/¹³⁴La as a PET Imaging Theranostic Pair for²²⁵Ac α-Radiotherapeutics 2023 ·Journal of Nuclear Medicine ·Kondapa Naidu Bobba, Anil P. Bidkar, Niranjan Meher, (unknown), (unknown), (unknown), (unknown), Scott Bidlingmaier, (unknown), Jiang He, David M. Wilson, Bin Liu, Youngho Seo, Henry F. VanBrocklin, Robert R. Flavell	19
10	CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment 2023 ·Journal of Experimental & Clinical Cancer Research ·Jun Li, Tao Huang, Jun Hua, Qiong Wang, Su Yang, Ping Chen, Scott Bidlingmaier, (unknown), Zhongqiu Xie, Anil P. Bidkar, Sui Shen, Weibin Shi, Youngho Seo, Robert R. Flavell, Daniel Gioeli, Robert Dreicer, Hui Li, Bin Liu, Jiang He	23
11	Highly efficient color-tunable organic co-crystals unveiling polymorphism, isomerism, delayed fluorescence for optical waveguides and cell-imaging 2023 ·Nature Communications ·Debasish Barman, Mari Annadhasan, Anil P. Bidkar, Pachaiyappan Rajamalli, (unknown), Siddhartha Sankar Ghosh, Rajadurai Chandrasekar, Parameswar Krishnan Iyer	62
12	Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers 2022 ·ACS Applied Materials & Interfaces ·Niranjan Meher, Gary W. Ashley, Anil P. Bidkar, (unknown), (unknown), Shaun D. Fontaine, Denis Beckford-Vera, David M. Wilson, Youngho Seo, Daniel V. Santi, Henry F. VanBrocklin, Robert R. Flavell	19
13	Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen 2021 ·ACS Applied Materials & Interfaces ·Niranjan Meher, Kyounghee Seo, Sinan Wang, Anil P. Bidkar, Matthew J. Fogarty, (unknown), Xiao Huang, (unknown), Charles Blaha, Michael J. Evans, David R. Raleigh, Young‐wook Jun, Henry F. VanBrocklin, Tejal A. Desai, David M. Wilson, Tomoko Ozawa, Robert R. Flavell	19
14	Nerve growth factor from Indian Russell’s viper venom (RVV-NGFa) shows high affinity binding to TrkA receptor expressed in breast cancer cells: Application of fluorescence labeled RVV-NGFa in the clinical diagnosis of breast cancer 2020 ·Biochimie ·(unknown), (unknown), Anil P. Bidkar, Siddhartha Sankar Ghosh, Rupak Mukhopadhyay, Yuri N. Utkin, Ashis K. Mukherjee	9
15	Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections 2020 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), (unknown), (unknown), (unknown), Anil P. Bidkar, Priyadarshi Satpati, Anirban Bhunia, Sunanda Chatterjee	23
16	Transferrin-Conjugated Red Blood Cell Membrane-Coated Poly(lactic-co-glycolic acid) Nanoparticles for the Delivery of Doxorubicin and Methylene Blue 2020 ·ACS Applied Nano Materials ·Anil P. Bidkar, Pallab Sanpui, Siddhartha Sankar Ghosh	39
17	Effect of Secondary Structure and Side Chain Length of Hydrophobic Amino Acid Residues on the Antimicrobial Activity and Toxicity of 14‐Residue‐Long de novo AMPs 2020 ·ChemMedChem ·(unknown), (unknown), (unknown), Anil P. Bidkar, Anirban Bhunia, Sunanda Chatterjee	29
18	Insights into the Mechanism of Antimicrobial Activity of Seven-Residue Peptides 2018 ·Journal of Medicinal Chemistry ·(unknown), Humaira Ilyas, (unknown), Anil P. Bidkar, (unknown), Anirban Bhunia, Priyadarshi Satpati, Sunanda Chatterjee	23
19	Studying in vitro phagocytosis of apoptotic cancer cells by recombinant GMCSF-treated RAW 264.7 macrophages 2017 ·International Journal of Biological Macromolecules ·Vanitha Selvarajan, Anil P. Bidkar, (unknown), Aditi Banerjee, (unknown), Siddhartha Sankar Ghosh, Pallab Sanpui	2
20	Protein folding and misfolding in the neurodegenerative disorders: A review 2014 ·Revue Neurologique ·Nityanand Bolshette, Krishan Kumar Thakur, Anil P. Bidkar, (unknown), Parveen Kumar, Ranadeep Gogoi	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact